KBLB Kraig Biocraft Laboratories, Inc.
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · OTC · SEC CIK 1413119 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-5.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-127.4%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets300.7%
Debt / equity—
Current ratio0.27x
Interest coverage-5.67x
Cash quality & payout
Operating cash flow / net income0.56x
Accruals ratio-56.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3,000 | — | — | — | — | — | — | — |
| Cost of revenue | $4,320 | — | — | — | — | — | — | — |
| Gross profit | -$1,320 | — | — | — | — | — | — | — |
| R&D expense | $132,284 | $64,369 | $66,701 | $68,751 | $9,243 | $63,888 | $23,876 | $60,557 |
| SG&A expense | $752,243 | $374,381 | $495,566 | $105,927 | $1.20M | $344,035 | $308,851 | $280,174 |
| Operating income | -$1.14M | -$703,433 | -$825,500 | -$722,668 | -$1.43M | -$637,745 | -$580,492 | -$715,916 |
| Interest expense | $153,385 | $151,399 | $148,433 | $144,120 | $144,255 | $141,986 | $140,348 | $135,890 |
| Pretax income | -$1.24M | -$909,535 | -$942,720 | -$787,621 | -$1.51M | -$726,133 | -$600,033 | -$851,675 |
| Net income | -$1.24M | -$909,535 | -$942,720 | -$787,621 | -$1.51M | -$726,133 | -$600,033 | -$851,675 |
| EBITDA | -$1.13M | -$696,331 | -$819,278 | -$715,066 | -$1.43M | -$631,908 | -$574,809 | -$709,864 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 1.12B | 1.11B | 1.09B | — | 1.07B | 1.05B | 1.04B | — |
| Balance sheet | ||||||||
| Cash & equivalents | $2.78M | $3.39M | $2.89M | $1.79M | $1.57M | $785,462 | $397,001 | $673,264 |
| Short-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $172,761 | $134,142 | $74,307 | $29,067 | $29,067 | $6,884 | $6,884 | $6,884 |
| Current assets | $3.02M | $3.57M | $3.01M | $1.87M | $1.64M | $838,975 | $452,714 | $740,285 |
| PP&E, net | $62,621 | $54,403 | $32,897 | $25,003 | $30,993 | $36,984 | $39,038 | $44,721 |
| Total assets | $3.74M | $4.27M | $3.72M | $2.57M | $2.36M | $1.59M | $1.32M | $1.51M |
| Current liabilities | $11.13M | $10.90M | $10.68M | $10.45M | $10.18M | $10.03M | $9.83M | $9.61M |
| Total liabilities | $11.24M | $11.02M | $10.78M | $10.56M | $10.31M | $10.06M | $9.86M | $9.65M |
| Shareholders' equity | -$7.50M | -$6.75M | -$7.06M | -$8.00M | -$7.96M | -$8.47M | -$8.55M | -$8.15M |
| Cash flow statement | ||||||||
| Operating cash flow | -$594,182 | -$598,695 | -$529,718 | -$449,487 | -$461,859 | -$443,125 | -$434,499 | -$512,523 |
| Capital expenditure | $13,662 | $28,608 | $14,116 | $1,612 | $0 | — | — | — |
| Free cash flow | -$607,844 | -$627,303 | -$543,834 | -$451,099 | -$461,859 | — | — | — |
| Investing cash flow | -$13,662 | -$28,608 | -$14,116 | $71,833 | $222,754 | — | — | — |
| Financing cash flow | $0 | $1.13M | $1.64M | $602,198 | $1.02M | $688,131 | $158,236 | $0 |
| Depreciation & amortization | $5,444 | $7,102 | $6,222 | $7,602 | $5,992 | $5,837 | $5,683 | $6,052 |
| Stock-based compensation | $29,115 | $29,085 | $29,085 | $29,095 | $29,095 | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.